Table 3. Demographic and clinical characteristics of 190 included men.

Patient and clinical parameters	Values*
Age (in years, mean ± SD)	69±8.7
PSA (in ng/mL, mean ± SD)	7±11.2
Training dataset (n=161)
PI-RADS category distribution
PI-RADS 3	18 [11]
PI-RADS 4	76 [47]
PI-RADS 5	67 [42]
Gleason sum score distribution
Gleason 3+3	47 [30]
Gleason 3+4	42 [26]
Gleason 4+3	36 [22]
Gleason 4+4	21 [13]
Gleason 4+5/5+4	15 [9]
Clinically significant cancer
Yes	114 [70]
No	47 [30]
Test dataset (n=40)
PI-RADS category distribution
PI-RADS 3	4 [10]
PI-RADS 4	20 [50]
PI-RADS 5	16 [40]
Gleason sum score distribution
Gleason 3+3	10 [25]
Gleason 3+4	11 [27]
Gleason 4+3	8 [20]
Gleason 4+4	8 [20]
Gleason 4+5/5+4	3 [8]
Clinically significant cancer
Yes	30 [75]
No	10 [25]

*, data in parentheses are percentages. PI-RADS, Prostate Imaging Reporting and Data System; PSA, prostate-specific antigen.